The Ebola virus has once again triggered an outbreak in the Democratic Republic of the Congo (DRC) and Uganda, renewing concerns over regional health security and the risk of wider international spread.
The World Health Organization (WHO) declared the outbreak a public health emergency of international concern on 17 May, citing the Bundibugyo virus strain for which there is currently no vaccine. The designation has affected response coordination, including treatment, containment efforts and health reporting, according to the WHO.
Official figures of 906 suspected cases in the DRC on 29 May have since been revised down to 321, with the WHO also confirming 48 deaths in the country. In Uganda, there have been nine WHO-confirmed cases and one death so far, Reuters reports, with Uganda's health ministry subsequently confirming six more cases.
Meanwhile, the European Union has allocated $17.4 million in humanitarian funding to support Ebola response and preparedness efforts in the DRC and Uganda. This includes $5.8 million earmarked for the WHO, alongside additional deliveries of emergency medical supplies and equipment.
Cases remain confined to the Democratic Republic of the Congo and Uganda at the time of writing, with no confirmed spread beyond the two countries. The possibility of cross-border transmission has raised wider international concern. A World Cup warm-up match involving the DRC was cancelled in Spain on 3 June over Ebola-related health fears.
Key takeaways
Ultimately, this research shows that combating AMR is no longer just a challenge for doctors. Because a warming planet directly strengthens and spreads ARGs, cutting carbon emissions must now be treated as a critical pillar of public health.
Responding to this growing environmental link, the World Health Assembly has adopted an updated Global Action Plan on AMR (2026-2036), establishing a comprehensive 'One Health' framework to coordinate global medical and environmental defences over the next decade.
Cuts to foreign aid budgets by the UK, Germany and France could contribute to more than 11.5 million preventable deaths by the end of the decade, according to a new report warning of a major retreat in global health and development support. The analysis finds sharp reductions in official development assistance across all three countries, says The Guardian, with researchers warning that scaling back funding for health and humanitarian programmes risks undermining global health systems and leaving vulnerable populations increasingly exposed to preventable disease and crisis.
Room size plays a major role in reducing airborne virus transmission, according to a new study published in Nature. Researchers in China and Hong Kong SAR found that more space per person helps dilute virus particles, lowering infection risk even in poorly ventilated settings. Current indoor air standards are insufficient, they warn, recommending guidelines that require both better ventilation and adequate space.
US regulators have approved an oral antiviral developed in Japan for post-exposure prevention of COVID-19, making it the first oral treatment shown to help prevent symptomatic infection regardless of vaccination status. The drug expands available options beyond vaccines and antibody treatments for reducing infection risk after exposure, reports Reuters.
An experimental oral treatment for ulcerative colitis has met its main goal in a late-stage clinical trial, with around half of patients achieving clinical remission compared with about 10% on placebo. The results suggest a potentially strong new option for treating the chronic inflammatory bowel condition.
The WHO is urging governments to strengthen rules to protect young people from addiction to tobacco and nicotine products, amid rising use of e-cigarettes and nicotine pouches. It warns that flavoured, heavily marketed products are driving youth uptake and calls for measures such as advertising bans, flavour restrictions and stronger enforcement of smoke-free laws.
Researchers at the University of Cambridge say they have developed a 'world-first' vaccine using artificial intelligence to design its key component. The early-stage vaccine aims to protect against a broad range of coronaviruses, including current COVID-19 variants and animal viruses that could trigger future pandemics. Initial trials in 39 people were designed to test safety and showed a modest immune response, with larger studies now planned. The team is also exploring AI-designed vaccines for flu, bird flu and viral haemorrhagic fevers such as Ebola.
The Annual Health Roundtable brought together ministers, executives, researchers and innovators in Geneva to move beyond diagnosing health system challenges and focus on practical design. Discussions explored how AI can reshape life sciences and care delivery, why AMR and non-communicable diseases require sustained cross-sector action and how health systems can help people live longer, healthier lives. The launch of the Global Virtual Health Alliance was a key milestone, advancing a vision of "health without walls" through more equitable, connected and scalable virtual care.
Women’s health system redesign: The women’s health gap remains a major global challenge, with misdiagnosis and delayed care affecting outcomes worldwide. Closing it could add at least $1 trillion a year to the global economy. Explore how health systems are being redesigned to close long-standing diagnostic gaps.
Tackling AMR: Can the rising tide of antibiotic resistance still be reversed? With drug misuse and a slowing pipeline of new treatments, experts warn the window to act is narrowing. This article explores what it would take to turn the trend around.
AI in healthcare: Data quality is the critical foundation for AI in healthcare, shaping whether new tools can deliver on diagnosis, treatment and system-wide efficiency. Poor data risks limiting the technology’s real-world impact, warns a health-tech VP.
此内容由惯性聚合(RSS阅读器)自动聚合整理，仅供阅读参考。 原文来自 — 版权归原作者所有。